Investigation of the effects of IL-13 and IL-22 cytokine levels on disease activity, prognosis, and treatment response in multiple sclerosis patients treated with fingolimod and glatiramer acetate.

Autor: Demir, Fidel¹ fideldemir2605@gmail.com, Kavak, Deniz Evrim¹, Karaaslan, Fırat², Aluçlu, Mehmet Ufuk², Kandemir, Sevgi Irtegun³

Publikováno v: Neurology Asia. Sep2024, Vol. 29 Issue 3, p763-771. 9p.

Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment.

Autor: Shobeirean A; Department of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran., Attar H; Department of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran., Varshochian R; Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. varshochian@sbmu.ac.ir., Rezvanfar MA; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences [Daru] 2024 Dec; Vol. 32 (2), pp. 649-664. Date of Electronic Publication: 2024 Sep 03.

Glatiramer Acetate Complexes CpG Oligodeoxynucleotides into Nanoparticles and Boosts Their TLR9-Driven Immunity.

Autor: Gong H; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Griffin JD; Kinimmune Inc., Saint Louis, Missouri 63141, United States., Groer CE; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Wu S; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Downes GM; Bioengineering Graduate Program, The University of Kansas, Lawrence, Kansas 66045, United States., Markum G; Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, Kansas 66047, United States., Abdelaziz MM; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Alhakamy NA; Kinimmune Inc., Saint Louis, Missouri 63141, United States.; Department of Pharmaceutics, King Abdulaziz University, Jeddah 21589, Saudi Arabia., Forrest ML; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Berkland CJ; Kinimmune Inc., Saint Louis, Missouri 63141, United States.; Department of Biomedical Engineering, Washington University, Saint Louis, Missouri 63105, United States.; Department of Chemistry, Washington University, Saint Louis, Missouri 63130, United States.

Publikováno v: Molecular pharmaceutics [Mol Pharm] 2024 Dec 02; Vol. 21 (12), pp. 6323-6338. Date of Electronic Publication: 2024 Nov 01.

Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?

Autor: Gil-Sánchez, Anna¹ (AUTHOR) agil@irblleida.cat, Gonzalo, Hugo¹ (AUTHOR) marc.ccss@icloud.com, Canudes, Marc¹ (AUTHOR) lara.noguerasp@gmail.com, Nogueras, Lara¹ (AUTHOR) cgonzalezm.lleida.ics@gencat.cat, González-Mingot, Cristina^1,2,3 (AUTHOR) ptorres@irblleida.cat, Valcheva, Petya¹ (AUTHOR) speralta.lleida.ics@gencat.cat, Torres, Pascual³ (AUTHOR), Serrano, Jose Carlos⁴ (AUTHOR) josecarlos.serrano@udl.cat, Peralta, Silvia^1,2 (AUTHOR) solanamoga@gmail.com, Solana, Maria José^1,2 (AUTHOR), Brieva, Luis^1,2,3 (AUTHOR) agil@irblleida.cat

Publikováno v: Pharmaceuticals (14248247). Apr2024, Vol. 17 Issue 4, p459. 14p.

Repurposing of glatiramer acetate to treat cardiac ischemia in rodent models.

Autor: Aviel G; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Elkahal J; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Umansky KB; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Bueno-Levy H; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Petrover Z; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Kotlovski Y; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Lendengolts D; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Kain D; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Shalit T; Bioinformatics Unit, G-INCPM, Weizmann Institute of Science, Rehovot, Israel., Zhang L; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Miyara S; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Kramer MP; The Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Merbl Y; The Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Kozlovski S; The Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel., Alon R; The Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel., Aharoni R; The Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel., Arnon R; The Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel., Mishali D; Pediatric Heart Institute, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel., Katz U; Pediatric Heart Institute, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Nachman D; Heart Institute, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel., Asleh R; Heart Institute, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel., Amir O; Heart Institute, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel., Tzahor E; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. eldad.tzahor@weizmann.ac.il., Sarig R; The Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. rachel.sarig@weizmann.ac.il.

Publikováno v: Nature cardiovascular research [Nat Cardiovasc Res] 2024 Sep; Vol. 3 (9), pp. 1049-1066. Date of Electronic Publication: 2024 Aug 26.